Seattle brothers expand billion-dollar biotech company's focus to include COVID
Harlan and Chad Robins started Seattle-based Adaptive Biotechnologies 12 years ago to find a cure for cancer. Now, they have broadened their mission to take on COVID-19. Adaptive s…